Three pharmaceutical stocks were last week's top performers — and analysts gave one 40% upside

Global stocks rose last week, tracking U.S. stocks as Wall Street's major indexes closed with weekly gains. The MSCI World index was up about 1% over the week, and all three U.S. indexes also set weekly gains , with the Nasdaq posting the largest increase.

However, Janssen Global Services on Saturday said it does not intend to make an offer, while Sanofi said if it decides to bid for Horizon, it would do so in cash, according to a Reuters report . An overwhelming majority of analysts who cover Horizon gave it a "buy" rating, although the average upside to price target that the stock got was limited, at 0.2%. Of all three, Catalent got the highest upside from analysts — getting a buy rating from 56% of those covering the stock.

대한민국 최근 뉴스, 대한민국 헤드 라인